Table 2 Medical Data
Item reduction | Validation phase | |
|---|---|---|
Period of transplantation, years | 6.8 ± 3.7 | 5.4 ± 3.14 |
Previous unsuccessful kidney transplants, % | - | 9.6 |
Patient with rejection | 23.2 | 21.4 % |
Cause of ESRD | ||
Chronic glomerular nephritis, % | 42 | 40.4 |
Diabetic nephropathy, % | 3 | 2.9 |
Vascular nephropathy, % | 4.5 | 3.8 |
Interstitial nephropathy, % | 13.5 | 10.6 |
Hereditary nephropathy,% | 17 | 23.1 |
Unclassified nephropathy,% | 20 | 19.2 |
Different modalities of dialysis | ||
Hemodialysis | 97.3 | 96.2 |
Peritoneal dialysis | 2.7 | 3.8 |
Duration of dialysis, years, mean ± SD | 2.5 ± 2 | 3.8 ± 4.2 |
Comorbidities | ||
Hypertension | 78.8 | 88.5 |
Diabetes | 13 | 13.5 |
Hepatitis | 0.6 | 6.7 |
Peripheral vascular disease | 0.6 | 5.8 |
Depression | - | 3.8 |
Smoking status | 36.5 | 31.1 |
BMI, kg/m2, mean ± SD | 25.5 ± 4.7 | 24.5 ± 4.0 |
Comorbidity index, mean ± SD | 1.6 ± 0.9 | 1.5 ± 0.8 |
Treatments | ||
Calcineurin inhibitors | 94.6 | 96.2 |
Corticosteroids | 89.3 | 97.1 |
Antimetabolites | 75.3 | 77.9 |
Antihypertensive drugs | 87.1 | 90.4 |
Antilipemic agents | 53.2 | 45.2 |
Antidiabetic agents | 9.7 | 15.4 |
Antithrombotics | 28.5 | 29.8 |
Protease Inhibitors | 19.9 | 26.0 |
Erythropoietin therapy | 12.2 | 10.6 |
Hospital admissions | ||
During the last 12 months | - | 45.2 |
Related to Kidney Transplantation | - | 66.0 |